ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,549 | -27.0% | 24,183 | -9.0% | 0.04% | -25.4% |
| Q2 2023 | $99,432 | +29.3% | 26,586 | +15.9% | 0.06% | +40.5% |
| Q1 2023 | $76,876 | -49.7% | 22,948 | -27.8% | 0.04% | -47.5% |
| Q4 2022 | $152,775 | +71.7% | 31,762 | +102.8% | 0.08% | +128.6% |
| Q3 2022 | $89,000 | -19.1% | 15,660 | +0.7% | 0.04% | -14.6% |
| Q2 2022 | $110,000 | -21.4% | 15,548 | -19.6% | 0.04% | -34.9% |
| Q1 2022 | $140,000 | -23.5% | 19,333 | -5.6% | 0.06% | -8.7% |
| Q4 2021 | $183,000 | -41.5% | 20,481 | +129.3% | 0.07% | -50.0% |
| Q3 2021 | $313,000 | +55.0% | 8,932 | -4.9% | 0.14% | +66.3% |
| Q2 2021 | $202,000 | – | 9,395 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |